ALLURION TECHNOLOGIES, INC.

Offers a swallowable gastric balloon & digital platform for non-surgical weight loss.

ALUR | NYSE

Overview

Corporate Details

ISIN(s):: US02008G1022
LEI:
Country:: United States of America
Address:: 11 HURON DR STE 200, 1760 NATICK
Website:: https://www.allurion.com/en
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Allurion Technologies, Inc. is a medical technology company dedicated to ending obesity. The company develops and markets the Allurion Program, a comprehensive weight-loss platform centered around the world's first and only swallowable, procedure-less gastric balloon. The program integrates the medical device with a full digital ecosystem, including the Allurion App, a Connected Scale, and an AI-powered coach, to provide real-time tracking and support. This is combined with professional nutritional coaching and medical supervision over a minimum six-month period. The platform is designed to help patients achieve and maintain metabolically healthy weight loss without surgery or endoscopy, and is available through a global network of partner clinics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ALLURION TECHNOLOGIES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALLURION TECHNOLOGIES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ALLURION TECHNOLOGIES, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TACTILE SYSTEMS TECHNOLOGY INC Develops at-home therapy devices for chronic swelling and respiratory conditions.	United States of America	TCMD
TANDEM DIABETES CARE INC Designs and sells advanced automated insulin delivery (AID) systems for people with diabetes.	United States of America	TNDM
TASCOM Co.,Ltd. Develops and markets point-of-care diagnostic instruments and diabetes management supplies.	South Korea	336040
Techno Medica Co., Ltd. Develops automated pre-analytical equipment for labs, specializing in tube labeling systems.	Japan	6678
TELA Bio, Inc. Markets reinforced biologic tissue for hernia repair and plastic & reconstructive surgery.	United States of America	TELA
TELEFLEX INC Global provider of single-use medical devices for critical care and surgical applications.	United States of America	TFX
Tenon Medical, Inc. Develops a minimally invasive implant for sacroiliac joint fusion to treat lower back pain.	United States of America	TNON
TERUMO CORPORATION Global provider of medical devices, pharma, and blood & cell technology solutions for healthcare.	Japan	4543
THE BioMed Co., Ltd. Develops Lab-on-a-Chip point-of-care systems for rapid, on-site in-vitro diagnostics.	South Korea	214610
Theradiag Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.	France	ALTER